Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions

Journal of Clinical Epidemiology

Volumn 60, Issue 7, 2007, Pages 696-703

  Opmeer, B C ^a   Heydendael, V M R ^a   deBorgie, C A J M ^a   Spuls, Ph I ^a   Bossuyt, P M M ^a   Bos, J D ^a   de Rie, M A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Decision making; Patient participation; Preference assessment; Psoriasis; Trade off; Vignette study

Indexed keywords

7 (3,5 DI TERT BUTYLPHENYL) 3 METHYL 2,4,6 OCTATRIENOIC ACID; CYCLOSPORIN; METHOTREXATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DECISION MAKING; FEMALE; HEALTH CARE; HUMAN; MALE; PATIENT PARTICIPATION; PHOTOTHERAPY; PREFERENCE ASSESSMENT; PRIORITY JOURNAL; PSORIASIS VULGARIS; PUVA; QUALITY ADJUSTED LIFE YEAR; SAFETY; STRUCTURED INTERVIEW; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VIGNETTE;

ACITRETIN; ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; DERMATOLOGIC AGENTS; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; METHOTREXATE; PATIENT SATISFACTION; PSORIASIS; PUVA THERAPY; QUESTIONNAIRES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 34250030209     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.10.011     Document Type: Article

References (18)

1. Spuls P.I., Bossuyt P.M., van Everdingen J.J., Witkamp L., and Bos J.D. The development of practice guidelines for the treatment of severe plaque form psoriasis. Arch Dermatol 134 (1998) 1591-1596
2. Spuls P.I., Witkamp L., Bossuyt P.M., and Bos J.D. A systematic review of five systemic treatments for severe psoriasis. Br J Dermatol 137 (1997) 943-949
3. van de Kerkhof P.C., de Hoop D., de Korte J., Cobelens S.A., and Kuipers M.V. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 200 (2000) 292-298
4. Nolting S.K., Sanchez C.S., De Boulle K., and Lambert J.R. Oral treatment schedules for onychomycosis: a study of patient preference. Int J Dermatol 37 (1998) 454-456
5. Wensing M., and Elwyn G. Improving the quality of health care: methods for incorporating patients' views in health care. BMJ 326 (2003) 877-895
6. Ryan M., Scott D.A., Reeves C., Bate A., van Teijlingen E.R., Russell E.M., et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 5 5 (2001) 1-186
7. Ryan M., and Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 320 7248 (2000) 1530-1533
8. Heydendael V.M., Spuls P.I., Opmeer B.C., de Borgie C.A., Reitsma J.B., Goldschmidt W.F., et al. Methotrexate versus cyclosporin in moderate-to-severe chronic plaque psoriasis. N Engl J Med 349 (2003) 658-665
9. Slovic P., Kahneman D., and Tversky A. The construction of preference (2000), University Press, Cambridge 489-502
10. Payne J.W., Bettman J.R., and Schkade D.A. Measuring constructed preferences: towards a building code. J Risk Uncertainty 19 (1999) 1-3
11. Poyner T.F., Menday A.P., and Williams Z.V. Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol. J Eur Acad Dermatol Venereol 14 (2000) 153-158
12. Housman T.S., Mellen B.G., Rapp S.R., Fleischer Jr. A.B., and Feldman S.R. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 70 (2002) 327-332
13. Zug K.A., Littenberg B., Baughman R.D., Kneeland T., Nease R.F., Sumner W., et al. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Arch Dermatol 131 (1995) 561-568
14. Weinstein G.D., and White G.M. An approach to the treatment of moderate to severe psoriasis with rotational therapy. J Am Acad Dermatol 28 (1993) 454-459
15. Holmes-Rovner M., Llewellyn-Thomas H., Entwistle V., Coulter A., O'Connor A., and Rovner D.R. Patient choice modules for summaries of clinical effectiveness: a proposal. BMJ 322 (2001) 664-667
16. Dowie J. The role of patients' meta-preferences in the design and evaluation of decision support systems. Health Expect 5 (2002) 16-27
17. Lloyd A.J. Threats to the Estimation of Benefit: Are Preference Elicitation Methods Accurate?. Health Economics 12 (2003) 393-402
18. Sculpher M., Bryan S., Fry P., de Winter P., Payne H., Emberton M., et al. Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ 328 (2004) 382-386